OGN vs PRU · P/E 3.4, rev $3.02B vs rev $31.19B
Organon & Co (OGN) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
PRU (PRU) common stock.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PRU currently screens at market cap $0.
Not investment advice. Open the OGN and PRU stock pages for the full models.
Not investment advice.